ImmuneOnco Biopharmaceuticals (Shanghai) Inc

01541

Company Profile

  • Business description

    ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

  • Contact

    1000 Zhangheng Road
    Unit 15, China (Shanghai) Pilot Free Trade Zone
    Pudong New Area
    Shanghai
    CHN

    T: +86 2138016387

    https://cn.immuneonco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    195

Stocks News & Analysis

stocks

3 Warren Buffett stocks to avoid today

These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks

Should you invest in small caps?

With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio. 
stocks

Strong second half anticipated for ASX mining play

A more focused business model should benefit the company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,079.2017.700.20%
CAC 407,870.6875.260.97%
DAX 4023,739.47204.640.87%
Dow JONES (US)46,247.29299.970.65%
FTSE 1009,284.8370.850.77%
HKSE26,128.20356.48-1.35%
NASDAQ22,484.0799.370.44%
Nikkei 22545,354.99399.94-0.87%
NZX 50 Index13,111.7342.06-0.32%
S&P 5006,643.7038.980.59%
S&P/ASX 2008,787.7013.200.15%
SSE Composite Index3,828.1125.20-0.65%

Market Movers